RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Carlos A. Sariol and Esther Torres.
Connection Strength

0.661
  1. Espino AM, Armina-Rodriguez A, Alvarez L, Ocasio-Malav? C, Ramos-Nieves R, Rodriguez Martin? EI, L?pez-Marte P, Torres EA, Sariol CA. The Anti-SARS-CoV-2 IgG1 and IgG3 Antibody Isotypes with Limited Neutralizing Capacity against Omicron Elicited in a Latin Population a Switch toward IgG4 after Multiple Doses with the mRNA Pfizer-BioNTech Vaccine. Viruses. 2024 01 26; 16(2).
    View in: PubMed
    Score: 0.240
  2. L?pez-Marte P, Soto-Gonz?lez A, Ramos-Tollinchi L, Torres-Jorge S, Ferre M, Rodr?guez-Martin? E, Torres EA, Sariol CA. Inefficient Induction of Neutralizing Antibodies against SARS-CoV-2 Variants in Patients with Inflammatory Bowel Disease on Anti-Tumor Necrosis Factor Therapy after Receiving a Third mRNA Vaccine Dose. Vaccines (Basel). 2022 Aug 11; 10(8).
    View in: PubMed
    Score: 0.217
  3. Rodr?guez-Martin? E, Medina-Prieto R, Santana-Bagur J, Sant? M, Pantoja P, Espino AM, Sariol CA, Torres EA. Early immunologic response to mRNA COVID-19 vaccine in patients receiving biologics and/or immunomodulators. medRxiv. 2021 Sep 15.
    View in: PubMed
    Score: 0.204
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support